Frontlight ResearchEarly access
Trial site
Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST
- 4running trials
- 2closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Myeloproliferative neoplasms2 trials
- Colorectal cancer1 trial
- Gastric and oesophageal cancer1 trial
- Liver and biliary tract cancer1 trial
- Ovarian cancer1 trial
- Prostate cancer1 trial
- Phase
- Phase 23 trials
- Phase 33 trials
- Status
- Recruiting3 trials
- Active, not recruiting1 trial
- Completed1 trial
- Terminated1 trial
- Lead sponsor
- Karyopharm Therapeutics Inc2 trials
- BeiGene1 trial
- OSE Immunotherapeutics1 trial
- SOTIO Biotech AG1 trial
- Taiho Oncology, Inc.1 trial
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Myeloproliferative neoplasms1 recruiting
Closed trials
Terminated
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026